Dr. Smith has over 20 years of biopharmaceutical industry experience in the United States, Europe, Canada and Asia, […] Most recently, he was Chief Executive Officer and member of the Board of Directors of GlycoVaxyn for seven years. EXHIBIT 99.1 ANTARES PHARMA ANNOUNCES THE APPOINTMENT OF PETER S. GREENLEAF TO COMPANY’S BOARD OF DIRECTORS EWING, N.J., December 13, 2018 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Leonard S. Jacob, M.D., Ph.D., Chairman of the Board of Antares Pharma, stated, “We are pleased to announce the addition of a seasoned pharmaceutical executive to the Antares Board of Directors. EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated , which was renamed to Ocata Therapeutics in November 2014. Dr. Wotton joined Antares Pharma as President and Chief Operating Officer on July 7, 2008, having over 20 years of experience in the pharmaceutical industry with both large and specialty pharma companies. Name Total COMPENSATION; Anton G. Gueth: Total Cash $221,747: Jacques Gonella, Ph.D. Total Cash $7,500: Mr. Samson is an expert in injectable manufacturing and... | October 7, 2020 Prior to Ocata, he served as President and Chief Executive Officer and as a member of the board of directors of Antares Pharma, Inc., as Chief Executive Officer of Topigen Pharmaceuticals, and as the Global Head of Business Development of SkyePharma PLC. Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella. Dr. Smith has over 20 years of biopharmaceutical industry experience in the United States, Europe, Canada and Asia, and currently … EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the election of Marvin Samson to the Company's Board of Directors. Antares Pharma Announces the Appointment of Peter S. Greenleaf to Company’s Board of Directors /EIN News/ -- EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. See the breakdown of the total annual compensation for Karen L. Smith, M.D., Ph.D. for being a board member of ANTARES PHARMA INC, as well as other members of the Board of Directors for ANTARES PHARMA INC – USA, NJ – Antares Pharma, Inc. (NASDAQ:ATRS) today announced the appointment of Dr. Karen Smith to the Company’s Board of Directors, filling the seat being vacated by the retirement of Dr. Jacques Gonella. EWING, N.J., March 04, 2019 -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Dr. Karen Smith to the Company’s Board of Directors, filling the seat. Antares Pharma, Inc. today announced the election of Marvin Samson to the Company's Board of Directors. EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Philippe has 20 years of experience in the life science industry, including pharma, biotech and med-tech companies. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella March 04 2019 - 07:00AM GlobeNewswire Inc.